# A Study Comparing CoQ10 Levels While Taking 3 Different Statins

Study · id `cardio:ct-nct01660191` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01660191](<https://clinicaltrials.gov/study/NCT01660191>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01660191

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.

## Technical summary

Registry record NCT01660191. Randomized; double masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2013-08 (actual). Results posted on 2017-01-18.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 134 participants (enrolled count; ClinicalTrials.gov record NCT01660191, source copy `cardio:ctgov-nct01660191-2017-01-18`, retrieved 2026-10-31)
- Start date: 2011-12 (registry gives no type) (ClinicalTrials.gov record NCT01660191, source copy `cardio:ctgov-nct01660191-2017-01-18`, retrieved 2026-10-31)
- Primary completion: 2013-08 (actual) (ClinicalTrials.gov record NCT01660191, source copy `cardio:ctgov-nct01660191-2017-01-18`, retrieved 2026-10-31)
- Completion: 2013-10 (actual) (ClinicalTrials.gov record NCT01660191, source copy `cardio:ctgov-nct01660191-2017-01-18`, retrieved 2026-10-31)
- Results first posted: 2017-01-18 (ClinicalTrials.gov record NCT01660191, source copy `cardio:ctgov-nct01660191-2017-01-18`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT01660191, source copy `cardio:ctgov-nct01660191-2017-01-18`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01660191-2017-01-18`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study Comparing CoQ10 Levels While Taking 3 Different Statins
- Acronym: SPARQ
- Condition: Hypercholesterolemia
- Intervention (Drug): Pitavastin 4mg
- Intervention (Drug): Atorvastatin 20mg
- Intervention (Drug): Rosuvastatin 5mg
- Lead sponsor: University of Kansas Medical Center
- Lead sponsor class: OTHER
- Collaborator: Kowa Pharmaceuticals America, Inc.
- Collaborator class: INDUSTRY
- Collaborator: Eli Lilly and Company
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry lists this organization as the lead sponsor: University of Kansas Medical Center (`cardio:org-university-of-kansas-medical-center`)
- Registry lists this organization as a collaborator: Kowa Pharmaceuticals America, Inc. (`cardio:org-kowa-pharmaceuticals-america-inc`)
- Registry lists this organization as a collaborator: Eli Lilly and Company (`cardio:eli-lilly`)

## Provenance

Content hash: f9cd3b31b0b7ee73bbf15e86aac45c6c398391599a5087c27d3f9052ea3e51de
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
